Evidence map›Paper›PMID 41584902›Full record

ArticleEJHaem2026

Clonal Evolution and Lineage Switch from T-Cell Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia in Therapy-Resistant

Machiko Kawamura, Daichi Sadato, Masayuki Haruta, Nobuko Kubota, Yuka Harada, Takeshi Kobayashi, Noriko Doki, Fumio Kasai, Yu Nishimura, Hirofumi Kobayashi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Machiko KawamuraDepartment of Clinical Laboratory Medicine Saitama Cancer Center Saitama Japan.ORCID https://orcid.org/0000-0002-6138-1690
Daichi SadatoClinical Research and Trials Center Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
Masayuki HarutaResearch Institute for Clinical Oncology Saitama Cancer Center Saitama Japan.
Nobuko KubotaDepartment of Hematology Saitama Cancer Center Saitama Japan.
Yuka HaradaClinical Research and Trials Center Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
Takeshi KobayashiHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
Noriko DokiHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
Fumio KasaiRIKEN Cell Bank Cell Engineering Division RIKEN BioResource Research Center Tsukuba Japan.
Yu NishimuraDepartment of Pathology Saitama Cancer Center Saitama Japan.
Hirofumi KobayashiDepartment of Hematology Saitama Cancer Center Saitama Japan.
Nobuo MasekiDepartment of Hematology Saitama Cancer Center Saitama Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case Presentation: We report an adolescent Conclusion: This case illustrates that therapy-resistant Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

acute myeloid leukemiaadolescentclonal evolutionlineage switchPICALM::MLLT10T‐cell acute lymphoblastic leukemia

Identifiers

PMID41584902
PMCPMC12826991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.